Neurological Surgery Doctors in East Lansing, MI Accepting Medicare

5 Neurological Surgery doctors found. Showing 1 - 5

Mohamed H Elnabtity, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1575 Ramblewood Dr, Suite 200, East Lansing, MI 48823 Phone: 517-827-1800    Fax: 517-827-1642

Timothy M Heilman, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1575 Ramblewood Dr, Suite 200, East Lansing, MI 48823 Phone: 517-827-1800    Fax: 517-827-1642

Christopher J Abood, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1575 Ramblewood Dr, Suite 200, East Lansing, MI 48823 Phone: 517-827-1800    Fax: 517-827-1642

Dr. Omar Qahwash, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1575 Ramblewood Dr, Ste 200, East Lansing, MI 48823 Phone: 517-827-1800    Fax: 517-827-1805

Charles H Bill Ii, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1575 Ramblewood Dr, Suite 200, East Lansing, MI 48823 Phone: 517-827-1800    Fax: 517-827-1642

News Archive

CABI scientists highlight COVID-19 implications on food security in Kenya and Uganda

CABI scientists have conducted new research highlighting the impact of COVID-19 pandemic on food security in Kenya and Uganda with more than two-thirds of those surveyed having experienced economic hardship due to the pandemic.

Aeolus Pharmaceuticals' AEOL 10150 effective against mustard gas exposure

Aeolus Pharmaceuticals, Inc. reported that researchers from National Jewish Health and Lovelace Respiratory Research Institute have completed a series of preliminary studies demonstrating that AEOL 10150 protects lungs from whole mustard gas exposure in rats. Data were presented at the Regional CounterACT Countermeasures Against Chemical Threats Conference in Albuquerque, NM.

Study investigates effects of acidity on breast and pancreatic cancer cell lines

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Wayne State University have discovered that tumor cell survival relies on adaptation to acidic conditions in the tumor microenvironment.

CTI Life Sciences announces closing of second venture capital fund

CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan.

Study examines differences between Magnet- and Non-Magnet hospitals

Magnet recognition is considered a leading source for measuring organizational success in nursing. Magnet hospitals show higher job satisfaction and lower odds of patient mortality than non-Magnet hospitals. However, only nine percent of American hospitals are recognized as Magnet. Currently, there is little research into the causes of the differences between Magnet and non-Magnet hospitals, research that could create an infrastructure for positive change in nurse and patient outcomes.

Read more Medical News

› Verified 1 days ago